Wedbush analyst Laura Chico downgrades Vera Therapeutics (NASDAQ:VERA) from Outperform to Neutral and announces $8 price target.
Safety Shot Issues Warning To Its Shareholders
Safety Shot, Inc. (NASDAQ:SHOT) it has come to our attention that there are several disclosed short sellers publishing malicious defamatory, inaccurate articles about Safety Shot and its management in a willful attempt
